泰尼特医疗 THC
$283.33 −$3.13 (-1.09%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $284.00 +0.24%
开盘$280.00
昨收$286.46
当日区间$276.87 – $285.76
成交量631.7K
市值$22.55B
市盈率（TTM）8.3
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$6.28B+18.7% YoY
营业利润$1.72B+110.5% YoY
净利润$1.22B+110.5% YoY
摊薄每股收益$12.41+221.5% YoY
自由现金流$1.08B+39.2% YoY
经营现金流$1.28B
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率83.3%
营业利润率22.5%
净利率12.3%
净资产收益率61.3%
资产收益率9.5%
投入资本回报率19.8%
流动比率1.58
负债/资产比率69.6%
现金及投资$2.67B
总负债$13.24B
净现金（净负债）-$10.57B
自由现金流/营收14.1%
营收构成
2026/Q3 季度
按业务线
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 营业总收入 | $6.28B | $6.04B | $5.78B | $21.31B | $5.53B |
| 营业成本 | $983.00M | $984.00M | $961.00M | $3.78B | $1.01B |
| 毛利润 | $5.29B | $5.06B | $4.82B | $17.53B | $4.52B |
| 营业费用 | $3.57B | $3.62B | $3.53B | $14.09B | $3.65B |
| 销售及管理费用 | $2.17B | $2.23B | $2.17B | $8.71B | $2.22B |
| -管理费用 | $2.17B | $2.23B | $2.17B | $8.71B | $2.22B |
| 折旧、摊销与折耗 | $217.00M | $215.00M | $229.00M | $863.00M | $231.00M |
| -折旧与摊销 | $217.00M | $215.00M | $229.00M | $863.00M | $231.00M |
| 其他营业费用 | $1.18B | $1.17B | $1.12B | $4.52B | $1.20B |
| 营业利润 | $1.72B | $1.44B | $1.30B | $3.44B | $869.00M |
| 非经营性利息净收入（支出） | -$203.00M | -$204.00M | -$205.00M | -$821.00M | -$205.00M |
| 非经营性利息支出 | $203.00M | $204.00M | $205.00M | $821.00M | $205.00M |
| 其他收入（支出） | $62.00M | $107.00M | $42.00M | $182.00M | $17.00M |
| 权益法投资收益 | $64.00M | $65.00M | $51.00M | $264.00M | $83.00M |
| 特殊收益（费用） | -$39.00M | -$1.00M | -$50.00M | -$199.00M | -$103.00M |
| -减：其他特殊支出 | $11.00M | $3.00M | $27.00M | $83.00M | $49.00M |
| -减：核销 | $37.00M | $31.00M | $7.00M | – | – |
| -业务出售收益 | $9.00M | $33.00M | $1.00M | -$1.00M | -$5.00M |
| 其他非经营性收入（支出） | $37.00M | $43.00M | $41.00M | $117.00M | $37.00M |
| 税前利润 | $1.58B | $1.34B | $1.13B | $2.80B | $681.00M |
| 税费 | $360.00M | $295.00M | $226.00M | $433.00M | $37.00M |
| 净利润 | $1.22B | $1.05B | $906.00M | $2.37B | $644.00M |
| 持续经营利润 | $1.22B | $1.05B | $906.00M | $2.37B | $644.00M |
| 少数股东权益 | $219.00M | $219.00M | $204.00M | $960.00M | $273.00M |
| 归属母公司净利润 | $1.00B | $826.00M | $702.00M | $1.41B | $371.00M |
| 归属普通股股东净利润 | $1.00B | $826.00M | $702.00M | $1.41B | $371.00M |
| 基本每股收益 | $12.48 | $9.89 | $8.09 | $15.61 | $4.25 |
| 摊薄每股收益 | $12.41 | $9.84 | $8.01 | $15.49 | $4.22 |
| 每股股息 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -减：重组及并购费用 | – | – | $17.00M | $54.00M | $1.00M |
| 报告营业总收入 | – | – | – | $21.31B | $5.53B |
| -减：资本性资产减值 | – | – | – | $61.00M | – |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $31.59B | $30.68B | $31.20B | $29.68B | $29.68B |
| 流动资产合计 | $8.43B | $7.83B | $8.36B | $7.85B | $7.85B |
| 现金及现金等价物与短期投资 | $2.67B | $2.17B | $2.97B | $2.88B | $2.88B |
| -现金及现金等价物 | $2.67B | $2.17B | $2.97B | $2.88B | $2.88B |
| 应收款 | $4.55B | $4.62B | $4.36B | $3.86B | $3.86B |
| -应收账款 | $2.60B | $2.61B | $2.61B | $2.57B | $2.57B |
| -应收票据 | $434.00M | $414.00M | $395.00M | – | – |
| -其他应收款 | $1.52B | $1.60B | $1.36B | $1.29B | $1.29B |
| 预付资产 | $360.00M | $338.00M | $351.00M | $423.00M | $423.00M |
| 存货 | $340.00M | $338.00M | $343.00M | $348.00M | $348.00M |
| 其他流动资产 | $443.00M | $300.00M | $271.00M | $278.00M | $278.00M |
| 非流动资产合计 | $23.16B | $22.85B | $22.85B | $21.83B | $21.83B |
| 固定资产净值 | $6.29B | $6.26B | $6.25B | $7.45B | $7.45B |
| -固定资产原值 | $13.35B | $13.18B | $13.07B | $14.13B | $14.13B |
| -累计折旧 | -$7.06B | -$6.92B | -$6.81B | -$6.68B | -$6.68B |
| 商誉及其他无形资产 | $12.87B | $12.72B | $12.70B | $12.55B | $12.55B |
| -商誉 | $11.64B | $11.44B | $11.39B | $11.20B | $11.20B |
| -其他无形资产 | $1.23B | $1.28B | $1.32B | $1.35B | $1.35B |
| 一年以上递延资产 | $49.00M | $71.00M | $84.00M | $84.00M | $84.00M |
| 其他非流动资产 | $3.96B | $3.80B | $3.81B | $54.00M | $54.00M |
| 负债合计 | $22.00B | $21.98B | $22.35B | $20.70B | $20.70B |
| 流动负债合计 | $5.32B | $5.57B | $6.15B | $4.46B | $4.46B |
| 应付款 | $1.41B | $1.44B | $1.58B | $1.36B | $1.36B |
| -应付账款 | $1.39B | $1.37B | $1.34B | $1.36B | $1.36B |
| -应付税款合计 | $22.00M | $69.00M | $236.00M | $0.00 | $0.00 |
| 一年内应计费用 | $213.00M | $113.00M | $256.00M | $81.00M | $81.00M |
| 短期债务及融资租赁负债 | $164.00M | $160.00M | $81.00M | $79.00M | $79.00M |
| -一年内到期债务 | $164.00M | $160.00M | $81.00M | $79.00M | $79.00M |
| 一年内预提费用 | $317.00M | $292.00M | $303.00M | $276.00M | $276.00M |
| 其他流动负债 | $2.34B | $2.70B | $3.08B | $1.81B | $1.81B |
| 非流动负债合计 | $16.68B | $16.41B | $16.20B | $16.24B | $16.24B |
| 长期债务及融资租赁负债 | $13.08B | $13.09B | $13.13B | $13.09B | $13.09B |
| -长期债务 | $13.08B | $13.09B | $13.13B | $13.09B | $13.09B |
| 非流动负债 | $979.00M | $978.00M | $938.00M | $951.00M | $951.00M |
| 一年以上递延负债 | $529.00M | $325.00M | $199.00M | $240.00M | $240.00M |
| 员工福利 | $238.00M | $241.00M | $243.00M | $245.00M | $245.00M |
| 其他非流动负债 | $1.86B | $1.78B | $1.69B | $1.71B | $1.71B |
| 股东权益合计 | $9.59B | $8.70B | $8.85B | $8.97B | $8.97B |
| 股东权益 | $5.44B | $4.66B | $4.81B | $4.22B | $4.22B |
| 股本 | $8.00M | $8.00M | $8.00M | $8.00M | $8.00M |
| -普通股 | $8.00M | $8.00M | $8.00M | $8.00M | $8.00M |
| 资本公积 | $5.24B | $5.19B | $5.12B | $4.91B | $4.91B |
| 留存收益 | $6.94B | $5.94B | $5.12B | $4.42B | $4.42B |
| 减：库存股 | $6.57B | $6.31B | $5.26B | $4.94B | $4.94B |
| 不影响留存收益的损益 | -$178.00M | -$177.00M | -$179.00M | -$181.00M | -$181.00M |
| 少数股东权益 | $4.15B | $4.04B | $4.04B | $4.75B | $4.75B |
| 投资及预付款 | – | – | – | $1.44B | $1.44B |
| -可供出售证券 | – | – | – | $59.00M | $59.00M |
| -长期股权投资 | – | – | – | $1.38B | $1.38B |
| 一年以上应收账款 | – | – | – | $203.00M | $203.00M |
| 一年以上预付资产 | – | – | – | $50.00M | $50.00M |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | $1.28B | $585.00M | $1.64B | $3.54B | $731.00M |
| 持续经营经营活动现金流净额 | $1.28B | $585.00M | $1.64B | $3.54B | $731.00M |
| 持续经营净利润 | $1.22B | $1.05B | $906.00M | $2.37B | $644.00M |
| 持续经营损益 | -$4.00M | -$72.00M | $27.00M | -$33.00M | -$16.00M |
| 折旧、折耗与摊销 | $217.00M | $215.00M | $229.00M | $863.00M | $231.00M |
| 递延税款 | $227.00M | $137.00M | -$40.00M | $9.00M | -$42.00M |
| 其他非现金项目 | -$47.00M | -$9.00M | -$6.00M | $29.00M | $66.00M |
| 营运资金变动 | -$441.00M | -$785.00M | $493.00M | $140.00M | -$172.00M |
| -应收款变动 | $22.00M | -$5.00M | -$28.00M | $20.00M | -$48.00M |
| -存货变动 | -$38.00M | -$158.00M | $407.00M | -$73.00M | -$15.00M |
| -应付账款及应计费用变动 | -$404.00M | -$493.00M | -$145.00M | $209.00M | -$28.00M |
| -其他流动负债变动 | $10.00M | $36.00M | $0.00 | $9.00M | -$41.00M |
| -其他营运资金变动 | -$31.00M | -$165.00M | $259.00M | -$25.00M | -$40.00M |
| 投资活动现金流净额 | -$298.00M | -$203.00M | -$317.00M | -$1.28B | -$389.00M |
| 持续经营投资活动现金流净额 | -$298.00M | -$203.00M | -$317.00M | -$1.28B | -$389.00M |
| 固定资产购置及出售净额 | -$193.00M | -$164.00M | -$178.00M | -$972.00M | -$344.00M |
| 业务购买及出售净额 | -$71.00M | -$9.00M | -$121.00M | -$308.00M | -$42.00M |
| 投资购置及出售净额 | -$30.00M | -$22.00M | -$4.00M | $3.00M | -$2.00M |
| 其他投资变动净额 | -$4.00M | -$8.00M | -$14.00M | $2.00M | -$1.00M |
| 筹资活动现金流 | -$479.00M | -$1.18B | -$1.24B | -$2.40B | -$434.00M |
| 持续经营筹资活动现金流净额 | -$479.00M | -$1.18B | -$1.24B | -$2.40B | -$434.00M |
| 债务发行及偿还净额 | -$15.00M | -$12.00M | -$19.00M | -$96.00M | -$27.00M |
| 普通股发行净额 | -$255.00M | -$1.04B | -$318.00M | -$1.39B | -$198.00M |
| 其他筹资费用净额 | -$209.00M | -$125.00M | -$903.00M | -$919.00M | -$209.00M |
| 期末现金余额 | $2.67B | $2.17B | $2.97B | $2.88B | $2.88B |
| 现金净变动 | $504.00M | -$797.00M | $84.00M | -$136.00M | -$92.00M |
| 期初现金余额 | $2.17B | $2.97B | $2.88B | $3.02B | $2.98B |
| 自由现金流 | $1.08B | $417.00M | $1.46B | $2.53B | $367.00M |
暂无评论——快来第一个聊聊 THC。
登录后参与讨论。